Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)

View source ↗

Summary

Imperial College London is conducting a study to quantify 18kDa TSPO expression in the lungs of people with Pulmonary Arterial Hypertension and healthy controls…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Pulmonary Arterial Hypertension, Healthy | Status: RECRUITING